Professor Gulati is a professor at the University of Illinois, Chicago, and has served as the Director of the Pharmacokinetic and Pharmacodynamic Laboratory. Dr Anil Gulati has six inventions to his credit and has published more than 175 papers in peer reviewed journals and edited two books. Dr Gulati is also a member of many national and International scientific societies and has won a number of national and international awards. He has rich experience as head of a large number of research projects and has collaborations for research with some of the leading pharmaceutical companies of the world like Bristol-Myers Squibb, Baxter Healthcare and a number of research institutes all over the world. He also serves on the Board of Directors of Chandigarh-based Venus Remedies Ltd. Dr. Gulati has extensive experience in the evaluation of blood substitutes and is responsible for the contracted pre-clinical efficacy testing of HemoZyme�.